Details
Stereochemistry | ACHIRAL |
Molecular Formula | IO3 |
Molecular Weight | 174.9027 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | -1 |
SHOW SMILES / InChI
SMILES
[O-]I(=O)=O
InChI
InChIKey=ICIWUVCWSCSTAQ-UHFFFAOYSA-M
InChI=1S/HIO3/c2-1(3)4/h(H,2,3,4)/p-1
Molecular Formula | HIO3 |
Molecular Weight | 175.9106 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
The iodate ion is an oxoanion of iodine bearing a negative charge and containing three oxygen atoms. Because it is more stable than iodide, most health authorities preferentially recommend iodate as an additive to salt for correcting iodine deficiency. In humans and rats, oral bioavailability of iodine from iodate is virtually equivalent to that from iodide. When given intravenously to rats, or when added to whole blood or tissue homogenates in vitro or to foodstuff, iodate is quantitatively reduced to iodide by nonenzymatic reactions, and thus becomes available to the body as iodide. Therefore, except perhaps for the gastrointestinal mucosa, exposure of tissues to iodate might be minimal. At much higher doses given intravenously (i.e., above 10 mg/kg), iodate is highly toxic to the retina. Ocular toxicity in humans has occurred only after exposure to doses of 600 to 1,200 mg per individual. Oral exposures of several animal species to high doses, exceeding the human intake from fortified salt by orders of magnitude, pointed to corrosive effects in the gastrointestinal tract, hemolysis, nephrotoxicity, and hepatic injury.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Diagnosis and management of lymphoceles after renal transplantation. | 1988 Apr |
|
[Current problems in the pathogenesis and treatment of endemic goiter]. | 1990 |
|
[A volumetric increase in the submandibular glands due to an organic iodate contrast medium. A case report]. | 1993 Jan-Feb |
|
Regeneration of mammalian retinal pigment epithelium. | 1994 |
|
Iodised salt for preventing iodine deficiency disorders. | 2002 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:49:18 GMT 2023
by
admin
on
Fri Dec 15 16:49:18 GMT 2023
|
Record UNII |
877S7T6EXV
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
15454-31-6
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY | |||
|
300000031655
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY | |||
|
DTXSID90165657
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY | |||
|
1546442
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY | RxNorm | ||
|
84927
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY | |||
|
877S7T6EXV
Created by
admin on Fri Dec 15 16:49:18 GMT 2023 , Edited by admin on Fri Dec 15 16:49:18 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |